LUIS MUNOZ: Open Payments
NPI 1487019279 · VALHALLA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 10 payments from 8 companies in 2025. Trend: 2023 $428 · 2024 $607 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $147 |
| Corcept Therapeutics | 1 | $138 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $122 |
| Indivior Inc. | 1 | $29 |
| Seqirus USA Inc | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Korlym, VOQUEZNA, Ozempic, SUBLOCADE, Flucelvax, CAPLYTA, TRELEGY ELLIPTA, BREZTRI.
Industry payments across NY — which companies pay providers there.
